NEW YORK, NY — As October marks Breast Cancer Awareness Month, the public discourse is often dominated by narratives of early detection, pink ribbons, and the triumph of “finishing treatment.” However, for the hundreds of thousands of people living with metastatic breast cancer (MBC)—also known as Stage 4—the reality is far more complex, persistent, and urgent.
On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor Research and Support will spearhead its flagship global initiative, #LightUpMBC. This campaign serves as a vivid, luminous reminder that while the world focuses on awareness, the fight against the deadliest form of breast cancer remains a high-stakes, ongoing battle that requires immediate scientific intervention.
More than 325 landmarks across 50 U.S. states, 20 countries, and 195 cities will bathe their structures in the colors of the MBC awareness ribbon—teal, green, and pink. From the iconic spires of One World Trade Center in New York to the mist-covered falls of Niagara and the historic Portsmouth Memorial Bridge in New Hampshire, these lights serve as a global vigil for those lost and a clarion call to fund the research that could turn a terminal diagnosis into a manageable chronic condition.
The Reality of Stage 4: Defining the Invisible Struggle
To understand the necessity of the #LightUpMBC movement, one must first confront the medical reality of metastatic breast cancer. Unlike early-stage breast cancer, which may be treated with the intent to cure, MBC occurs when cancer cells spread from the breast to distant organs, most commonly the bones, liver, lungs, or brain.
Even when the cancer has traveled to a vital organ, it is biologically classified as breast cancer. It is not "lung cancer" or "bone cancer"; it remains breast cancer that has metastasized. For many patients, this diagnosis comes as a shock, appearing months, years, or even decades after the successful treatment of an earlier-stage disease. For others, the disease is identified as Stage 4 from the very first consultation.
The treatment landscape for MBC is one of constant vigilance. Because there is currently no cure, treatment is a lifelong process. Patients undergo therapies designed to control the spread of the disease, extend life, and preserve quality of life. However, cancer is a formidable opponent; it often evolves and develops resistance to existing therapies, forcing patients to navigate a revolving door of treatment regimens.
The human cost of this progression is staggering. In the United States alone, an estimated 42,670 people are projected to die from breast cancer in 2026. This translates to approximately 117 lives lost every single day. These statistics represent mothers, fathers, siblings, and friends—a community that METAvivor is working tirelessly to protect through the power of targeted research.
Chronology of a Movement: From Local Tribute to Global Phenomenon
The origins of #LightUpMBC are deeply rooted in personal loss and the desire for systemic change. The campaign was founded by Laura Inahara, whose best friend, Jessica Moore, passed away from metastatic breast cancer at the age of 36.
Inahara’s initial goal was modest: she hoped to see just one local landmark illuminated to honor Moore’s memory and shed light on the oft-ignored plight of the MBC community. That singular gesture in 2017—when the Portsmouth Memorial Bridge in New Hampshire became the first structure to light up—ignited a movement that has since grown exponentially.
The Timeline of Impact:
- 2017: The inaugural illumination of the Portsmouth Memorial Bridge marks the beginning of the #LightUpMBC movement.
- 2018–2020: The campaign gains momentum, expanding to major U.S. cities and attracting the attention of local governments and private landmark owners.
- 2021–2025: #LightUpMBC transitions into a global effort, incorporating a professional-grade livestream event, #LightUpMBC Live, to reach a worldwide audience.
- 2026: The campaign reaches its current pinnacle, involving 325 landmarks across 20 countries, having raised over $2.7 million to date for metastatic research.
What began as a localized act of mourning has evolved into an international advocacy force. The movement’s expansion reflects a growing global awareness that without dedicated funding for Stage 4 research, the mortality rates associated with breast cancer will remain stagnant.
The Scientific Imperative: Why METAvivor Stands Apart
While many organizations focus on general breast cancer awareness or early detection programs, METAvivor has carved out a unique, vital niche. It is one of the only nonprofits in the United States that exclusively funds research for Stage 4 metastatic breast cancer.
METAvivor’s approach to funding is rigorous and evidence-based. The organization employs a two-tiered review process:
- Scientific Peer Review: Applications for grants are evaluated by top-tier oncologists and researchers to ensure scientific merit and potential for clinical breakthroughs.
- Patient Advocate Review: Projects are vetted by metastatic breast cancer patients to ensure that the research addresses the needs that matter most to those living with the disease—specifically, extending life and improving quality of life.
By focusing exclusively on the terminal stage, METAvivor fills a critical gap in the medical research ecosystem. The funds raised through #LightUpMBC go directly toward these peer-reviewed grants, providing the seed money necessary for innovative clinical trials that larger, government-funded entities might deem too high-risk to pursue.
Voices from the Frontlines: Official Responses
The #LightUpMBC campaign is not merely a fundraising event; it is a platform for the community to share its narrative. The personal testimonials associated with this year’s event underscore the urgency of the mission.
Dr. Kelly Shanahan, a physician and the current Board President of METAvivor, has lived with her own metastatic diagnosis since 2013. "When I was diagnosed in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. Her story is a testament to the power of research. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and it is also a way to bring us together as a community."
Founder Laura Inahara emphasizes that the campaign’s success is a tribute to the legacy of those who have passed. "Jessica hoped to illuminate one local landmark," Inahara stated. "Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has raised millions for critical research."
LightUpMBC Live: A Global Gathering
On October 13, the campaign will culminate in the broadcast of #LightUpMBC Live. The event, scheduled for 8 p.m. ET / 5 p.m. PT, is designed to be as informative as it is emotional.
Program Highlights:
- Hosts: The event will be co-hosted by Tami Eagle Bowling, who has lived with MBC for 11 years, and Broadway star and breast cancer survivor Kara Lindsay.
- Artistic Contributions: The broadcast will feature performances from notable figures, including two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and voiceover artist Tony Daniels.
- Educational Components: The program will weave together patient narratives with segments on the latest scientific advancements in metastatic research, bridging the gap between the emotional experience of the patient and the analytical world of the researcher.
The event will be streamed for free via the METAvivor YouTube channel and their Facebook page, ensuring that the message of hope and advocacy reaches every corner of the globe.
Implications for the Future: Turning Awareness into Action
The implications of the #LightUpMBC campaign extend far beyond the single evening of illumination. By centralizing the focus on Stage 4, the campaign challenges the medical community and the public to rethink their approach to breast cancer.
For years, the "pink ribbon" culture has been criticized for glossing over the reality of death. #LightUpMBC shifts the narrative, acknowledging the terminal nature of the disease while aggressively pursuing the science that could change that outcome.
Why the Public Should Participate:
- Education: By engaging with the livestream, the public gains a nuanced understanding of why "early detection" is not a panacea and why metastatic research is the true frontier of the cancer battle.
- Support: The campaign provides a sense of community for the hundreds of thousands of patients who often feel isolated by their diagnosis.
- Financial Impact: As a nonprofit with a low administrative overhead, the funds raised by #LightUpMBC have a high "return on investment" regarding the research they support. 100% of net proceeds from the campaign are funneled directly into the grant-making process.
As night falls on October 13, the skyline of the world will change. The teal, green, and pink lights will serve as more than just a beautiful display; they will act as a collective demand for progress.
"We want to move the needle," says Tami Eagle Bowling, the campaign’s director. "Every dollar donated, every landmark lit, and every story shared brings us one step closer to a day when metastatic breast cancer is no longer a death sentence, but a condition we can manage and, eventually, cure."
For those wishing to contribute to the mission, view the list of participating landmarks, or watch the live event, information is available at www.lightupmbc.org. As the campaign encourages: Light up the night, so they can see the future.
About the Author
